TSUNO Takaya 津野隆哉

Researcher Number	60598259
Affiliation (based on the past Project Information) *help	2016 – 2017: 高知大学, 医学部, 研究員 2011 – 2015: 関西医科大学, 医学部, 助教
Review Section/Research Field	Principal Investigator Radiation science
Keywords	Principal Investigator 放射線治療 / IFN-α / アポトーシス / BID / 癌幹細胞 / BID遺伝子集学的治療 / BID遺伝子 / 集学的治療 / IFN / 幹細胞 … More / BID遺伝子治療 / apotosis / 遺伝子治療 / 分子標的療法 Less

Assessment of IFN-alpha activated BID gene/radiation combined modality therapy for human cancer stem cellsPrincipal Investigator
- Principal Investigator
  
  Tsuno Takaya
- Project Period (FY)
  2014 – 2017
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Radiation science
- Research Institution
  Kochi University
  Kansai Medical University
Assessment of immune-activated BID gene-radiation combined modality therapyPrincipal Investigator
- Principal Investigator
  
  TSUNO Takaya
- Project Period (FY)
  2011 – 2013
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Radiation science
- Research Institution
  Kansai Medical University

All 2017 2013 2012 2011 Other

All Journal Article Presentation

[Journal Article] BID is a critical factor controlling cell viability regulated by IFN-α2012
- Author(s)
  Tsuno T, Mejido J, Zhao T.
- Journal Title
  
  Phillips T, Myers TG, Bekisz J, Zoon KC. J Immunother
  
  Volume: 35 Issue: 1 Pages: 23-31
- DOI
  10.1097/cji.0b013e3182372dcf
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23791456
[Journal Article] BID is a critical factor controlling cell viability regulated by IFN-α2012
- Author(s)
  Takaya Tsuno, Josef Mejido, Tongmao Zhao, Terry Phillips, Timothy G. Myers, Joseph Bekisz, Kathryn C. Zoon
- Journal Title
  
  Journal of Immunotherapy
  
  Volume: 35 Pages: 23-31
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23791456
[Journal Article] A novel role for IFN-stimulated gene factor 3II in IFN-γsignaling and induction of antiviral activity in human cells2011
- Author(s)
  Morrow AN, Schmeisser H, Tsuno T, Zoon KC.
- Journal Title
  
  J Immunol
  
  Volume: 186 Issue: 3 Pages: 1685-1693
- DOI
  10.4049/jimmunol.1001359
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23791456
[Presentation] New drug repositioning of low-dose PEG-IFN-α in combination with BH3 interacting domain death agonist gene and radiation therapy as a cancer treatment regimen2017
- Author(s)
  Takaya Tsuno
- Organizer
  The American Association for Cancer Research Tumor Immunology and Immunotherapy Conference
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26461899
[Presentation] BH3 INTERACTING DOMAIN DEATH AGONIST GENE THERAPY ENHANCES ANTITUMOR EFFECT OF INTERFERON-ΑLPHA2013
- Author(s)
  津野隆哉
- Organizer
  第36回日本分子生物学会年会
- Place of Presentation
  神戸ポートピアアイランド(神戸市)
- Year and Date
  2013-12-05
- Data Source
  KAKENHI-PROJECT-23791456
[Presentation] BH3 INTERACTING DOMAIN DEATH AGONIST GENE THERAPY ENHANCES ANTITUMOR EFFECT OF INTERFERON-ΑLPHA2013
- Author(s)
  Takaya Tsuno
- Organizer
  Cytokines 2013
- Place of Presentation
  Hyatt Regency San Francisco (San Francisco, CA, USA)
- Year and Date
  2013-10-02
- Data Source
  KAKENHI-PROJECT-23791456
[Presentation] What is a critical factor controlling cell viability regulated by IFN-α?2011
- Author(s)
  津野隆哉
- Organizer
  第34回日本分子生物学会年会
- Place of Presentation
  パシフィコ横浜(横浜市)
- Year and Date
  2011-12-16
- Data Source
  KAKENHI-PROJECT-23791456
[Presentation] What is a critical factor controlling cell viability regulated by IFN-α?2011
- Author(s)
  津野　隆哉
- Organizer
  第34回日本分子生物学会年会
- Place of Presentation
  パシフィコ横浜（神奈川）
- Data Source
  KAKENHI-PROJECT-23791456
[Presentation] BH3 INTERACTING DOMAIN DEATH AGONIST GENE THERAPY ENHANCES ANTITUMOR EFFECT OF INTERFERON-ΑLPHA
- Author(s)
  津野　隆哉
- Organizer
  第36回日本分子生物学会年会
- Place of Presentation
  神戸ポートピアアイランド（神戸市）
- Data Source
  KAKENHI-PROJECT-23791456
[Presentation] BH3 INTERACTING DOMAIN DEATH AGONIST GENE THERAPY ENHANCES ANTITUMOR EFFECT OF INTERFERON-ALPHA
- Author(s)
  Takaya Tsuno
- Organizer
  Cytokines 2013
- Place of Presentation
  Hyatt Regency San Francisco (San Francisco, CA, USA)
- Data Source
  KAKENHI-PROJECT-23791456

1. 岩田亮一 (60580446)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
2. 八幡俊男 (40380323)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results

TSUNO Takaya 津野 隆哉

Research Projects

Research Products

Co-Researchers

Assessment of IFN-alpha activated BID gene/radiation combined modality therapy for human cancer stem cellsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Assessment of immune-activated BID gene-radiation combined modality therapyPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] BID is a critical factor controlling cell viability regulated by IFN-α2012

Author(s)

Journal Title

DOI

Data Source

[Journal Article] BID is a critical factor controlling cell viability regulated by IFN-α2012

Author(s)

Journal Title

Data Source

[Journal Article] A novel role for IFN-stimulated gene factor 3II in IFN-γsignaling and induction of antiviral activity in human cells2011

Author(s)

Journal Title

DOI

Data Source

[Presentation] New drug repositioning of low-dose PEG-IFN-α in combination with BH3 interacting domain death agonist gene and radiation therapy as a cancer treatment regimen2017

Author(s)

Organizer

Data Source

[Presentation] BH3 INTERACTING DOMAIN DEATH AGONIST GENE THERAPY ENHANCES ANTITUMOR EFFECT OF INTERFERON-ΑLPHA2013

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] BH3 INTERACTING DOMAIN DEATH AGONIST GENE THERAPY ENHANCES ANTITUMOR EFFECT OF INTERFERON-ΑLPHA2013

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] What is a critical factor controlling cell viability regulated by IFN-α?2011

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] What is a critical factor controlling cell viability regulated by IFN-α?2011

Author(s)

Organizer

Place of Presentation

Data Source

[Presentation] BH3 INTERACTING DOMAIN DEATH AGONIST GENE THERAPY ENHANCES ANTITUMOR EFFECT OF INTERFERON-ΑLPHA

Author(s)

Organizer

Place of Presentation

Data Source

[Presentation] BH3 INTERACTING DOMAIN DEATH AGONIST GENE THERAPY ENHANCES ANTITUMOR EFFECT OF INTERFERON-ALPHA

Author(s)

Organizer

Place of Presentation

Data Source

TSUNO Takaya 津野隆哉